Hemostemix (PK) Stock Quote HMTXF - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.0352

Bid

0.0301

Ask

0.0645

Volume

2,000

0.0352 Day's Range 0.0352

0.024 52 Week Range 0.1362

Market Cap

3.067M

Previous Close

0.04595

Open

0.0352

Last Trade

2000

0.0352

Last Trade Time

Financial Volume

$ 70

VWAP

0.0352

Average Volume (3m)

13,516

Shares Outstanding

87,122,318

Dividend Yield

PE Ratio

-1.39

Earnings Per Share (EPS)

-0.03

Revenue

200k

Net Profit

-2.5M

Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) fro... Hemostemix is an autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company has 87 patents on the derivation of angiogenic cell precursors (ACP-01), neuronal cell precursors (NCP-01) and cardiomyocyte cell precursors (CCP-01) from a synergetic cell population that is sourced from the patient's blood. The Company is selling exempt compassionate treatments to individuals afflicted with critical limb ischemia, for example, and conducting clinical trials to commercialize its lead product, ACP-01, for the treatment of critical limb ischemia and peripheral arterial disease, and heart disease (ischemic cardiomyopathy, dilated cardiomyopathy). Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Website

www.hemostemix.com

Headquarters

Calgary, Alberta, Can

Founded

2014

Hemostemix Inc (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker HMTXF. The last closing price for Hemostemix (PK) was $0.05. Over the last year, Hemostemix (PK) shares have traded in a share price range of $ 0.024 to $ 0.1362.

Hemostemix (PK) currently has 87,122,318 shares outstanding. The market capitalization of Hemostemix (PK) is $4 million. Hemostemix (PK) has a price to earnings ratio (PE ratio) of -1.39.

Financing & Partnership News Send Shares of this Stem-Cell Therapy Company on a Tear

While most stock indices are in the red today, shares of this pioneering stem cell firm are soaring following this morning's news of an LOI. In a press release this morning, Hemostemix Inc To read...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.0067	23.5087719298	0.0285	0.04595	0.024	24597	0.0349697	CS
4	0.0044	14.2857142857	0.0308	0.04595	0.024	11256	0.03496147	CS
12	0.0013	3.83480825959	0.0339	0.046	0.024	13516	0.03719794	CS
26	-0.0222	-38.6759581882	0.0574	0.0758	0.024	12151	0.04273604	CS
52	-0.0548	-60.8888888889	0.09	0.1362	0.024	24797	0.07944204	CS
156	-0.1467	-80.6487080814	0.1819	0.3279	0.024	18962	0.15047203	CS
260	0.0072	25.7142857143	0.028	0.4372	0.0049	35534	0.0838917	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUZENuZee Inc	$ 2.04 (98.06%)	2.87M
ALLRAllarity Therapeutics Inc	$ 0.2558 (53.63%)	43.33M
NIVFNewGenIvf Group Ltd	$ 1.24 (42.38%)	4.85M
MGOLMGO Global Inc	$ 4.07 (18.66%)	80.19k
SLNASelina Hospitality PLC	$ 0.0304 (16.92%)	49.21M
VSTMVerastem Inc	$ 2.6697 (-25.64%)	463.63k
IONMAssure Holdings Corporation	$ 1.8201 (-25.10%)	73.06k
SLRXSalarius Pharmaceuticals Inc	$ 2.09 (-19.92%)	259.53k
ALPPAlpine 4 Holdings Inc	$ 0.4989 (-16.84%)	308.87k
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 11.50 (-16.06%)	19.06M
SLNASelina Hospitality PLC	$ 0.0304 (16.92%)	49.21M
ALLRAllarity Therapeutics Inc	$ 0.2558 (53.63%)	43.33M
TSLATesla Inc	$ 226.62 (-8.02%)	20.36M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 11.50 (-16.06%)	19.06M
HOLOMicroCloud Hologram Inc	$ 0.5652 (-3.35%)	10.15M